- Home
- BNTC vs EDD Comparison
BNTC vs EDD Comparison
Compare BNTC & EDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTC
- EDD
- Stock Information
- Founded
- BNTC 1995
- EDD 2007
- Country
- BNTC United States
- EDD United States
- Employees
- BNTC N/A
- EDD N/A
- Industry
- BNTC Biotechnology: Pharmaceutical Preparations
- EDD Finance Companies
- Sector
- BNTC Health Care
- EDD Finance
- Exchange
- BNTC Nasdaq
- EDD Nasdaq
- Market Cap
- BNTC 339.8M
- EDD 307.8M
- IPO Year
- BNTC N/A
- EDD N/A
- Fundamental
- Price
- BNTC $15.66
- EDD $4.88
- Analyst Decision
- BNTC Strong Buy
- EDD
- Analyst Count
- BNTC 7
- EDD 0
- Target Price
- BNTC $24.43
- EDD N/A
- AVG Volume (30 Days)
- BNTC 37.6K
- EDD 254.3K
- Earning Date
- BNTC 05-12-2025
- EDD 01-01-0001
- Dividend Yield
- BNTC N/A
- EDD 7.52%
- EPS Growth
- BNTC N/A
- EDD N/A
- EPS
- BNTC N/A
- EDD N/A
- Revenue
- BNTC N/A
- EDD N/A
- Revenue This Year
- BNTC N/A
- EDD N/A
- Revenue Next Year
- BNTC N/A
- EDD N/A
- P/E Ratio
- BNTC N/A
- EDD N/A
- Revenue Growth
- BNTC N/A
- EDD N/A
- 52 Week Low
- BNTC $4.75
- EDD $4.22
- 52 Week High
- BNTC $15.97
- EDD $4.95
- Technical
- Relative Strength Index (RSI)
- BNTC 73.53
- EDD 64.45
- Support Level
- BNTC $11.99
- EDD $4.71
- Resistance Level
- BNTC $15.97
- EDD $4.81
- Average True Range (ATR)
- BNTC 1.03
- EDD 0.05
- MACD
- BNTC 0.33
- EDD 0.00
- Stochastic Oscillator
- BNTC 93.76
- EDD 85.00
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
About EDD Morgan Stanley Emerging Markets Domestic Debt Fund Inc.
Morgan Stanley Emerging Markets Domestic Debt Fund Inc is a closed-end management investment company. The company's primary investment objective is to seek a high level of current income, with a secondary investment objective of long-term capital appreciation. It seeks to achieve investment objectives by investing, under normal circumstances, at least 80% of its managed assets in emerging markets domestic debt. The fund's portfolio includes sovereign, quasi-sovereign, corporate bonds in emerging markets.